Patents for A01K 67 - Rearing or breeding animals, not otherwise provided for; New breeds of animals (34,042)
05/2006
05/04/2006US20060095978 Screening assay
05/04/2006US20060093604 Method of treatment and prophylaxis
05/04/2006US20060093600 Antibodies to CD40
05/04/2006CA2585970A1 Mammalian genes involved in infection
05/04/2006CA2584814A1 Suppression of endogenous immunoglobulin expression in non-human transgenic animals
05/04/2006CA2584489A1 Kaspp (lrrke) gene, its production and use for the detection and treatment of neurodegenerative disorders
05/03/2006EP1651050A1 Acellular tissue matrices made from galactose alpha-1,3-galactose -deficient tissue
05/03/2006EP1651031A1 Procedure of genetic recombination for galinaceae hybrids breeding
05/03/2006EP1651030A1 Method for genetic improvement of terminal boars
05/03/2006EP1240822B1 Diabetes onset model mammal
05/03/2006CN1254173C Earthworm excrement deodorizing method and apparatus
05/03/2006CN1254172C Method for obtaining inbreeding line small size pig
05/02/2006US7038107 Elimination of endogenous porcine retrovirus
05/02/2006US7038106 Detection of neural activity
05/02/2006US7038105 Evaluation of therapeutic agent for use in the treatment of schizophrenia; obtain animal model, administer therapeutic agent, monitor animal behavior, evaluate for reduction in schizophrenic activity
05/02/2006US7038014 Seafood protein; measuring water absorption of fish bladder
05/02/2006US7037701 Genetic engineering; detection moderators of kinase peptidespeptides
05/02/2006US7037647 Prostate-specific membrane antigen and uses thereof
05/02/2006US7037498 Antibodies to insulin-like growth factor I receptor
05/02/2006US7036454 Insect holder
04/2006
04/27/2006WO2006044962A1 Method for generating an animal homozygous for a genetic modification
04/27/2006WO2006044336A1 Methods for increasing the diversity of monoclonal antibodies produced against an antigen
04/27/2006WO2006044332A2 Animal model systems for viral pathogenesis of neurodegeneration, autoimmune demyelination, and diabetes
04/27/2006WO2006027545A3 Method
04/27/2006WO2005116070A9 Reporter system for detecting signal pathway activation in multiple cell types
04/27/2006WO2005086825A3 Methods and compositions for treatment of diseases associated with aberrant microsatellite expansion
04/27/2006US20060090221 Transgenic plant or a yeast cell containing recombinant nucleic acid having a promoter sequence linked to a heterologous nucleic acid that hybridizes under high-stringency conditions with a specific nucleic acid probe and encodes a protein having Delta 8 fatty acid desaturase activity
04/27/2006US20060090214 Method of treatment and an animal model useful for same
04/27/2006US20060090213 Transgenic mice containing Kir5.1 inwardly rectifying potassium channel gene disruptions
04/27/2006US20060090212 Novel human genes and proteins encoded thereby
04/27/2006US20060089320 Modulation of type IIß phosphoinositide phosphate kinase
04/27/2006US20060089306 New epilepsy mutations
04/27/2006US20060088913 Mutation associated with epilepsy
04/27/2006US20060088898 Methods for the production of cells and mammals with desired genetic modifications
04/27/2006US20060088893 Prostate cancer therapeutics and diagnostics based on conformers of prostatic cid phosphatase
04/27/2006US20060088837 Expression system for stem-loop rna molecule having rnai effect
04/27/2006US20060088835 Schizophrenia associated genes
04/27/2006US20060088832 Tap-70, a novel marker for epithelial tumors
04/27/2006US20060088827 Diagnostic and therapeutic use of a voltage-gated ion channel scn2a for neurodegenerative diseases
04/27/2006CA2827654A1 Method for generating an animal homozygous for a genetic modification
04/27/2006CA2584512A1 Truncated fragments of alpha-synuclein in lewy body disease
04/27/2006CA2584108A1 Development of sensitive fret sensors and methods of using the same
04/27/2006CA2583799A1 Methods for increasing the diversity of monoclonal antibodies produced against an antigen
04/27/2006CA2583750A1 Methods for generating a rodent having a genetic modification
04/26/2006EP1650294A1 Production of avian embryonic germ (EG) cell lines by prolonged culturing of PGCS, use thereof for cloning and chimerization
04/26/2006EP1649746A1 MSH5 ablated mice and uses therefor
04/26/2006EP1648918A2 Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
04/26/2006EP1648224A1 Rat model of diabetic nephropathy
04/26/2006EP1648223A1 Npc1l1 (npc3) and methods of use thereof
04/26/2006EP1421377B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use
04/26/2006EP1147137B1 Methods for generating phosphorylation site-specific immunological reagents
04/26/2006CN2774113Y Folium mori picker
04/26/2006CN1764728A Porcine polymorphisms and methods for detecting them
04/26/2006CN1763180A Preparation method for different species triploid prawn
04/26/2006CN1762227A Nutrition regulation method with increased content of milk CLA(conjugate linoleic acid) and feed stuff
04/26/2006CN1762211A Separation method of young ground beetles
04/25/2006US7034201 Developmental animal model of temporal lobe epilepsy
04/25/2006US7034200 Non-human transgenic animals expressing platelet-derived growth factor C (PDGF-C) and uses thereof
04/25/2006US7034115 Transposase and method of gene modification
04/25/2006US7034114 Polypeptide for use in the treatment of inflammation, atherosclerosis, nervous system, blood, muscular, connective tissue and cancer disorders
04/25/2006US7033794 Basolateral sorting signal and inhibitors thereof
04/25/2006US7033585 Immunologically privileged cells and uses thereof
04/25/2006US7032537 Method and housing assembly for farming members of the phylum arthropoda
04/25/2006CA2353520C Animal model for psoriasis for the prevention and treatment of psoriasis in humans
04/20/2006WO2006042223A2 Old-35 as an inflammatory agent
04/20/2006WO2006042147A2 Large-scale production of recombinant transmembrane and cytosolic proteins
04/20/2006WO2006041759A2 Transgenic frog lines and assays employing them
04/20/2006WO2006041225A1 Polynucleotide for production of recombinant protein by silkworm
04/20/2006WO2006040926A1 Method of growing fish by transplanting genital cell with the use of triploid recipient
04/20/2006WO2006040594A2 Nek kinase (nima related kinase) proteins
04/20/2006WO2005060625A3 Grp receptor-related methods for treating and preventing fear-related disorders
04/20/2006US20060085866 Incorporating donor mouse embryonic stem cell, homozygous for genetic modification, into pre-morula host embryo, recovering progeny
04/20/2006US20060085865 Transgenic mice containing GPCR-like gene disruptions
04/20/2006US20060084799 Human cDNA clones comprising polynucleotides encoding polypeptides and methods of their use
04/20/2006US20060084623 DNA vaccination for treatment of multiple sclerosis and insulin-dependent diabetes mellitus
04/20/2006US20060084118 Lymphocytes; transcription factors; interferons; diagnosis of autoimmune disease such as lupus
04/20/2006US20060083740 By modulating the expression of mutant and wild type CD83 gene products produced in a mammal; regulation of T cell and dendritic cell activity; antibodies
04/20/2006US20060083722 Methods and compositions for cell therapy
04/20/2006US20060083712 Methods and compositions for the repair and/or regeneration of damaged myocardium
04/20/2006US20060083686 Therapeutic agent for ulcerative colitis
04/20/2006DE19754938B4 TGC-Verfahren zur Induktion einer zielgerichteten, somatischen Transgenität TGC method for inducing a targeted somatic transgenic
04/19/2006EP1292187B1 Transgenic animal model of neurodegenerative disorders
04/19/2006CN1761756A Depletion of endogenous primordial germ cells in avian species
04/19/2006CN1761755A Gene trap system
04/19/2006CN1251584C Method for culturing transgenic fowls
04/18/2006US7030291 CYT28 serpentine receptor disruptions, compositions and methods relating thereto
04/18/2006US7030290 Comprises trangenic caenorhabditis elegans mutants associated with constitutive pharyngeal pumping, increased gut permeability and/or altered molecular transport for use as animal model and drug screening tools
04/18/2006US7030289 Protection of proteins (e.g. fibrinogen) expressed in milk from transgenic animals by co-expression of a serine proteinase inhibitor (e.g. alpha 1-antitrypsin) in the milk of the transgenic animals.
04/18/2006US7030225 Antibodies to JTT-1 protein, cells secreting such antibodies, and methods of making such antibodies
04/18/2006US7030098 DNA vaccination for treatment of autoimmune disease
04/18/2006US7029894 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
04/18/2006US7029664 Chicken leukemia inhibitory factor (LIF)
04/18/2006US7029441 Animal healthcare, well-being and nutrition
04/18/2006CA2231880C Method for analyzing the immunosuppressant activity of ion channel blockers using the mini-pig
04/13/2006WO2006039678A2 Establishment of highly metastatic cell lines using nog mice
04/13/2006WO2006039476A2 Animal model for hepatitis c virus infection
04/13/2006WO2006039418A2 Human monoclonal antibodies to fc gamma receptor ii (cd32)
04/13/2006WO2006038729A1 Mutated amyloid protein
04/13/2006WO2006037327A2 Polypeptides having phytase activity and polynucleotides encoding same
04/13/2006WO2006037263A1 Method for establishing gonochoristic shellfish selfing line